2017 tables: Institutions - corporate

The 2017 tables are based on Nature Index data from 1 January 2016 to 31 December 2016.

Table criteria

# Institution Share 2015 Share 2016 Count 2016 Change in Adjusted Share 2015-2016*
1 AstraZeneca plc, United Kingdom (UK) 24.04 31.19 112 33.1%
2 GlaxoSmithKline plc. (GSK), United Kingdom (UK) 26.58 15.72 67 -39.3%
3 Anglo American plc, United Kingdom (UK) 3.30 2.71 12 -15.9%
4 Johnson Matthey (JM), United Kingdom (UK) 2.99 2.02 6 -30.6%
5 Unilever, United Kingdom (UK) 1.01 1.86 14 88.6%
6 GlaxoSmithKline R&D Ltd., United Kingdom (UK) 1.20 1.85 9 58.4%
7 BP plc, United Kingdom (UK) 3.09 1.16 11 -61.6%
8 LGC Limited, United Kingdom (UK) 1.42 1.09 3 -21.1%
9 Earlham Institute (EI), United Kingdom (UK) 0.19 1.01 5 444.4%
10 Rio Tinto plc, United Kingdom (UK) 0.05 0.85 9 1,645.6%
11 Wessex Water Services Ltd., United Kingdom (UK) 0.33 0.83 2 156.4%
12 Vernalis plc, United Kingdom (UK) 0.74 2 N/A
13 GEO Specialty Chemicals, Inc., United Kingdom (UK) 0.69 2 N/A
14 Stallergenes Greer plc., United Kingdom (UK) 0.67 1 N/A
15 F2G Ltd., United Kingdom (UK) 0.64 1 N/A
16 BAE Systems, United Kingdom (UK) 0.21 0.59 3 181.9%
17 Capita plc, United Kingdom (UK) 0.13 0.58 4 379.5%
18 Vivid Economics, United Kingdom (UK) 0.58 1 N/A
19 Dŵr Cymru Welsh Water (DCWW), United Kingdom (UK) 0.53 2 N/A
20 Oxford Instruments, United Kingdom (UK) 1.67 0.53 4 -67.4%
21 Severn Trent Water Ltd., United Kingdom (UK) 0.14 0.50 2 259.0%
22 Oxford Photovoltaics Limited (Oxford PV), United Kingdom (UK) 0.49 3 N/A
23 IQE plc, United Kingdom (UK) 0.20 0.44 1 127.9%
24 rdscientific, United Kingdom (UK) 0.43 3 N/A
25 Oxford Nanopore Technologies Ltd., United Kingdom (UK) 0.20 0.43 2 121.0%
26 Thames Water Utilities Limited, United Kingdom (UK) 0.20 0.40 2 105.1%
27 Royal Society Of Chemistry (RSC), United Kingdom (UK) 0.38 1 N/A
27 kMatrix Ltd., United Kingdom (UK) 0.38 1 N/A
28 Ludger Ltd., United Kingdom (UK) 0.12 0.36 2 211.0%
29 GlaxoSmithKline Harlow, United Kingdom (UK) 0.10 0.34 2 253.4%
30 Molecular Warehouse Ltd., United Kingdom (UK) 0.14 0.33 1 139.3%
30 Phytatec (UK ) Ltd., United Kingdom (UK) 0.33 1 N/A
30 Sporomex Limited, United Kingdom (UK) 0.33 1 N/A
30 JD Geoconsultancy Limited, United Kingdom (UK) 0.33 1 N/A
31 Scancell Holdings PLC, United Kingdom (UK) 0.32 1 N/A
32 Kore Technology Ltd., United Kingdom (UK) 0.30 1 N/A
33 WS Atkins plc, United Kingdom (UK) 0.05 0.29 6 518.0%
33 Rolls-Royce plc, United Kingdom (UK) 0.16 0.29 6 86.1%
34 Scottish Water, United Kingdom (UK) 0.18 0.29 1 61.2%
35 Randgold Resources Limited, United Kingdom (UK) 0.25 1 N/A
35 Ricardo Energy and Environment, United Kingdom (UK) 0.25 1 N/A
35 Photek Ltd., United Kingdom (UK) 0.25 1 N/A
35 Polar Scientific Ltd., United Kingdom (UK) 0.25 1 N/A
36 QinetiQ Group plc, United Kingdom (UK) 0.25 0.24 2 -2.3%
37 Horizon Discovery Ltd., United Kingdom (UK) 1.05 0.20 2 -80.3%
38 Pharmidex, United Kingdom (UK) 0.04 0.20 1 371.8%
38 Malvern Instruments Ltd., United Kingdom (UK) 1.48 0.20 1 -86.1%
38 Hydro International Ltd., United Kingdom (UK) 0.20 1 N/A
38 Southern Water Services Ltd., United Kingdom (UK) 0.20 1 N/A
38 Herpetofauna Consultants International (HCI), United Kingdom (UK) 0.20 1 N/A
38 Badrilla Ltd., United Kingdom (UK) 0.20 1 N/A
38 Cairn Energy PLC, United Kingdom (UK) 0.20 1 N/A
38 Ikon Science, United Kingdom (UK) 0.20 1 N/A
39 Fluidic Analytics, Ltd., United Kingdom (UK) 0.19 3 N/A
40 pSiMedica Ltd., United Kingdom (UK) 0.19 1 N/A
41 Kymab Limited, United Kingdom (UK) 0.18 1 N/A
42 Cambridge Display Technology Ltd., United Kingdom (UK) 1.22 0.18 1 -84.7%
42 Synome Ltd., United Kingdom (UK) 0.18 1 N/A
43 Midland Valley Exploration Ltd., United Kingdom (UK) 0.15 2 N/A
44 Motac Neuroscience Ltd., United Kingdom (UK) 0.11 0.14 2 32.3%
45 The Henry Stewart Group, United Kingdom (UK) 0.29 0.14 1 -49.4%
45 ARUP, United Kingdom (UK) 0.14 1 N/A
45 SSBN Limited, United Kingdom (UK) 0.14 1 N/A
45 F1000Research, United Kingdom (UK) 0.14 1 N/A
45 Spalding Associates (Environmental) Ltd., United Kingdom (UK) 0.14 1 N/A
45 CARE Fertility, United Kingdom (UK) 0.14 1 N/A
46 Immunocore Limited, United Kingdom (UK) 0.14 1 N/A
47 BioPharmaSpec Ltd., United Kingdom (UK) 0.14 2 N/A
48 Selcia Limited, United Kingdom (UK) 0.14 0.13 1 -4.3%
49 FlexEnable Ltd., United Kingdom (UK) 0.13 1 N/A
49 Palaeocreations, United Kingdom (UK) 0.13 1 N/A
49 Sellafield Ltd., United Kingdom (UK) 0.13 1 N/A
49 Manchester Nanomaterials Limited, United Kingdom (UK) 0.13 1 N/A
49 NQuiX Ltd., United Kingdom (UK) 0.13 1 N/A
49 Scicate Limited, United Kingdom (UK) 0.13 1 N/A
49 Yorkshire Water Services Ltd., United Kingdom (UK) 0.13 1 N/A
50 Getech, United Kingdom (UK) 0.11 1 N/A
50 Octimet Oncology Ltd., United Kingdom (UK) 0.11 1 N/A
50 Multivalent Ltd., United Kingdom (UK) 0.11 1 N/A
51 Isoprime Ltd., United Kingdom (UK) 0.10 1 N/A
51 Hiden Isochema, United Kingdom (UK) 0.10 1 N/A
51 Palynova, United Kingdom (UK) 0.10 1 N/A
51 Crescendo Biologics Ltd., United Kingdom (UK) 0.10 1 N/A
51 PraxisUnico, United Kingdom (UK) 0.10 1 N/A
52 Envigo, United Kingdom (UK) 0.09 1 N/A
52 Albumedix Ltd., United Kingdom (UK) 0.09 1 N/A
53 Oxford Gene Technology, United Kingdom (UK) 0.04 0.08 2 127.0%
54 Canterbury Archaeological Trust Ltd., United Kingdom (UK) 0.08 1 N/A
55 MOF Technologies Ltd., United Kingdom (UK) 0.25 0.07 1 -70.7%
55 Cresset Biomolecular Discovery, United Kingdom (UK) 0.07 1 N/A
55 United Utilities Group PLC, United Kingdom (UK) 0.07 1 N/A
55 GeoScience Limited, United Kingdom (UK) 0.07 1 N/A
56 Isomerase Therapeutics Ltd., United Kingdom (UK) 0.10 0.07 1 -31.6%
56 Mitopharm Ltd., United Kingdom (UK) 0.07 1 N/A
57 Kongsberg Maritime Ltd., United Kingdom (UK) 0.06 1 N/A
57 Randox Laboratories Ltd., United Kingdom (UK) 0.06 1 N/A
58 Cancer Research Technology Ltd. (CRT), United Kingdom (UK) 1.00 0.06 1 -94.0%
58 Cyprotex Discovery Ltd., United Kingdom (UK) 0.06 1 N/A
59 SLR Consulting Limited, United Kingdom (UK) 0.06 1 N/A
59 Global Phasing Limited, United Kingdom (UK) 0.57 0.06 1 -90.0%
59 Autifony Therapeutics Limited Company, United Kingdom (UK) 0.06 1 N/A
60 Korrigan Sciences Limited, United Kingdom (UK) 0.08 0.05 1 -29.8%
61 Isca Diagnostics, United Kingdom (UK) 0.05 1 N/A
61 Silence Therapeutics, United Kingdom (UK) 0.05 1 N/A
61 Cambridge Epigenetix (CEGX), United Kingdom (UK) 0.05 1 N/A
62 Genomics England Ltd., United Kingdom (UK) 0.05 3 N/A
63 DougalEARTH Ltd., United Kingdom (UK) 0.05 1 N/A
63 York Osteoarchaeology Ltd., United Kingdom (UK) 0.05 1 N/A
63 ADAS UK Ltd., United Kingdom (UK) 0.05 1 N/A
64 Bio Nano Consulting, United Kingdom (UK) 0.10 0.05 1 -53.4%
65 Flamingo Land Ltd., United Kingdom (UK) 0.04 2 N/A
66 Heygates Limited, United Kingdom (UK) 0.03 1 N/A
67 Inivata, United Kingdom (UK) 0.03 1 N/A
68 Molecular Sense Ltd., United Kingdom (UK) 0.03 1 N/A
69 Cellular Therapeutics Ltd., United Kingdom (UK) 0.03 1 N/A
70 HR Wallingford Ltd., United Kingdom (UK) 0.02 0.02 1 -4.3%
71 Lab-Tools Ltd., United Kingdom (UK) 0.02 1 N/A
71 Cambridge Cell Networks Ltd (CCNet Ltd), United Kingdom (UK) 0.02 1 N/A
72 First Light Fusion Ltd., United Kingdom (UK) 0.02 1 N/A
73 Oncimmune Limited, United Kingdom (UK) 0.02 1 N/A
74 HCA Laboratories Limited, United Kingdom (UK) 0.02 0.01 1 -64.8%
75 Smith & Nephew plc, United Kingdom (UK) 0.03 0.00 1 -94.0%

Footnote

Each year, the Nature Index publishes tables based on counts of high-quality research outputs in the previous calendar year. Users please note:

  1. The data behind the tables are based on a relatively small proportion of total research papers, they cover the natural sciences only and outputs are non-normalized (that is, they don’t reflect the size of the country or institution, or its overall research output).
  2. The Nature Index is one indicator of institutional research performance. The metrics of Count and Share used to order Nature Index listings are based on an institution’s or country’s publication output in 82 natural-science journals, selected on reputation by an independent panel of leading scientists in their fields.
  3. Nature Index recognizes that many other factors must be taken into account when considering research quality and institutional performance; Nature Index metrics alone should not be used to assess institutions or individuals.
  4. Nature Index data and methods are transparent and available under a creative commons licence at natureindex.com.

The Nature Index database undergoes regular updating, corrections, adjustment of institutional hierarchies, and removal of retracted papers and thus the live website can differ from the frozen annual tables.

*The change in adjusted Share accounts for the small annual variation in the total number of articles in Nature Index journals. Share values have been adjusted to 2020 levels to calculate the percentage change. For more information on the adjustment, please see the Adjusted metric explainer.